NFS1 and breast cancer: Previous work from the Possemato’s lab has showed that suppression of ISC biosynthesis in Basal-like breast cancer, by loss of NFS1, leads to increased levels of DNA damage and loss of viability and identified Polε as the ISC-containing protein that underlies this phenotype20.